IGF-1 LR3 Dosing Protocol & Schedule IGF-1 LR3 dosing is reported in micrograms (mcg) , not milligrams
Research has examined its role in: 3-adrenergic receptor upregulation and adipose tissue sensitisation studies Lipolysis stimulation and plasma glycerol elevation in adipocyte models Lipogenesis inhibition and fat accumulation prevention in diet-induced obesity models Fat oxidation and energy expenditure pathway research Metabolic flexibility and substrate oxidation studies in obese murine models Cartilage regeneration and intra-articular joint biology in osteoarthritis models Safety pharmacology genotoxicity, bioavailability, and plasma kinetics profiling Comparative hGH fragment activity studies alongside AOD9401 and native hGH AOD9604 and Adipose Tissue Research In obese Zucker rats treated with oral AOD9604 at 500 g/kg body weight for 19 days, over 50% reduction in body weight gain was observed compared to controls, accompanied by significantly increased lipolytic activity in adipose tissue
The peptide also inhibits glycogen synthase kinase-3 beta (GSK-3), an enzyme implicated in various neurodegenerative processes
Clinical studies on Lipotropics and obesity have remained indecisive
Bacteriostatic water contains a small amount of preservative that helps prevent bacterial growth, allowing multiple withdrawals from the same vial when handled using proper laboratory procedures
Finally, the scientific community is constantly debating the gap between internet hype and clinical literature
